ArticleThe Lancet regional health. Europe2023

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.

Marc Sapoval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.